Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2026-02-22 @ 7:23 AM
Study NCT ID:
NCT04114461
Status:
COMPLETED
Last Update Posted:
2020-05-12
First Post:
2019-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers
Sponsor:
Hanlim Pharm. Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HL-TOF-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None